Erectile dysfunction: Is platelet-rich plasma the new frontier for treatment in patients with erectile dysfunction? A review of the existing evidence
Erectile dysfunction (ED) is one of the commonest disorders in adult males and affects 12–19% of men of reproductive age. Only few studies have evaluated the impact of ED on men and couples with infertility—these studies report higher rates of ED in this sub-group of men compared to the general popu...
Main Authors: | Eleni Anastasiadis, Razna Ahmed, Abbas Khizar Khoja, Tet Yap |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Reproductive Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/frph.2022.944765/full |
Similar Items
-
Revisiting the Regenerative Therapeutic Advances Towards Erectile Dysfunction
by: Ming-Che Liu, et al.
Published: (2020-05-01) -
Platelet-rich plasma: application for interstitial cystitis and erectile dysfunction
by: R. G. Khamedov, et al.
Published: (2022-04-01) -
Blood platelet activity in men with vasculogenic erectile dysfunction
by: Zeki Bayraktar, et al.
Published: (2017-03-01) -
Early Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile Dysfunction
by: Tuncay Taş, MD, et al.
Published: (2021-04-01) -
The relationship between platelet–lymphocyte ratio and severity of erectile dysfunction
by: Alpaslan Akbas, et al.
Published: (2016-02-01)